As reported on Business Wire, Stanford Medicine Cancer Center has reported a significant milestone in radiation oncology, completing the world’s first patient treatment using a compact upright proton therapy system. The procedure, performed on June 4, 2026, marks a transition from experimental development to early clinical adoption for a novel approach designed to expand access to proton therapy.
At the center of this advancement is Leo Cancer Care’s Marie® upright patient positioning platform, integrated with the Mevion S250-FIT™ Proton Therapy System and supported by RaySearch’s RayStation software. Notably, the first patient treated was a pediatric case, highlighting the potential importance of this innovation for vulnerable populations.
A Shift Toward More Accessible Proton Therapy
Proton therapy is known for its ability to deliver highly targeted radiation while minimizing exposure to surrounding healthy tissues. This precision is particularly beneficial in pediatric oncology, where reducing long-term side effects is critical. However, widespread adoption has been limited due to the cost and infrastructure requirements of conventional systems.
Traditional proton therapy installations rely on large rotating gantries and purpose-built facilities, typically occupying more than 29,000 square feet. In contrast, the compact system used at Stanford requires approximately 1,700 square feet—representing a dramatic reduction in space and potentially in cost.
This downsizing is made possible by a key innovation: rather than rotating the radiation beam around a stationary patient, the Marie® platform rotates the patient 360 degrees relative to a fixed beam. This mechanical simplification allows proton systems to fit into existing radiotherapy vaults, opening the door for broader adoption across cancer centers that previously lacked the required infrastructure.
From Concept to Clinical Reality
Leo Cancer Care has spent more than a decade developing upright radiotherapy technology. While treating patients in a seated or standing position is not a new idea, previous attempts faced practical limitations that hindered widespread clinical implementation.
The Stanford deployment represents the first time a compact proton therapy system combined with upright positioning has been used to treat a patient, demonstrating that the concept can function effectively in a real-world clinical setting. The milestone provides early validation of a design philosophy centered on reducing system complexity while improving usability.
Enhancing the Patient Experience
Beyond technical efficiency, the upright approach aims to improve the overall treatment experience. Patients are positioned in a way that more closely aligns with natural posture, which may reduce discomfort associated with prolonged immobilization in conventional supine setups.
Preliminary evaluations suggest that patients tolerate upright positioning well, reporting ease of breathing and comfort during treatment. The configuration also allows for direct, face-to-face interaction between patients and clinicians—an aspect largely absent in traditional radiotherapy environments.
This human-centered design may be especially meaningful for pediatric patients. In addition to the physical setup, Leo Cancer Care has introduced supportive tools such as an interactive game, “StatueQuest,” designed to help children remain still during treatment while reducing anxiety.
Technical Integration and Workflow Potential
The Marie® system incorporates a rotating chair and integrated upright CT imaging, enabling imaging and treatment to occur in the same position. This can streamline workflows by reducing the need for repositioning between imaging and therapy, which is often required in conventional approaches.
At Stanford, researchers are continuing to evaluate several operational factors, including patient setup time, immobilization techniques, and treatment planning flexibility. These assessments will be critical in determining whether upright proton therapy can match or exceed current standards in efficiency and clinical outcomes.
Broader Implications for Radiation Oncology
The introduction of compact upright proton therapy could have far-reaching implications. By lowering the physical and financial barriers associated with installation, the technology has the potential to expand access to advanced radiation treatments worldwide.
Historically, proton therapy has been limited to highly specialized centers due to its scale and cost. Enabling installation in existing facilities could significantly increase the number of institutions capable of offering this modality, particularly in regions where access has been limited.
Industry collaboration will play a role in determining how quickly adoption grows. Leo Cancer Care and Mevion Medical Systems plan to continue working together to support additional installations and further clinical research into upright treatment delivery.
Looking Ahead
While this first treatment represents an important proof of concept, further clinical experience will be needed to fully establish the benefits and limitations of upright proton therapy. Ongoing data collection at Stanford and future sites will inform how the approach compares with traditional methods in terms of outcomes, efficiency, and patient satisfaction.
Still, the milestone signals a meaningful evolution in how proton therapy may be delivered. By rethinking both the physical design of treatment systems and the patient experience, compact upright solutions could reshape access to one of radiation oncology’s most advanced modalities.
